US Patent Issued to Cytune Pharma on June 23 for "IL-2/IL-15R beta gamma agonist dosing regimens for treating cancer or infectious diseases" (Czech, French, German Inventors)

ALEXANDRIA, Va., July 15 -- United States Patent no. 12,661,387, issued on June 23, was assigned to Cytune Pharma (Nantes, France).

"IL-2/IL-15R beta gamma agonist dosing regimens for treating cancer or infectious diseases" was invented by Ulrich Moebius (Gauting Unterbrunn, Germany), David Bechard (Saint-Etienne de Montluc, France), Irena Adkins (Prezletice, Czech Republic) and Nada Podzimkova (Jindrichuv Hradec, Czech Republic).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides pulsed cyclic administration regimes and pulsed administration regimes for interleukin-2/interleukin-15 receptor BetaGamma (IL-2/IL-15RBetaGamma) agonists for treating or managing cancer or infectious disea...